[go: up one dir, main page]

MA28302A1 - SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES - Google Patents

SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES

Info

Publication number
MA28302A1
MA28302A1 MA29201A MA29201A MA28302A1 MA 28302 A1 MA28302 A1 MA 28302A1 MA 29201 A MA29201 A MA 29201A MA 29201 A MA29201 A MA 29201A MA 28302 A1 MA28302 A1 MA 28302A1
Authority
MA
Morocco
Prior art keywords
diseases
treatment
sulfonamide derivatives
conditions
derivatives
Prior art date
Application number
MA29201A
Other languages
French (fr)
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Paul Alan Glossop
Kim James
Charlotte Alice Louise Lane
Russell Andrew Lewthwaite
Ian Brian Moses
David Anthony Price
Nicholas Murray Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28302(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of MA28302A1 publication Critical patent/MA28302A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

DEPOSANT Société dite : PFIZER INC. REVENDICATION DE PRIORITES EP 22 Janvier 2004 04290169.4 GB 22 Mars 2004 0406387.1 US 9 Août 2004 60/600,260 Voir en annexe le titre de 1'invention et le texte de 1'abrégé Dérivés de sulfonamides pour le traitement de maladies L'invention concerne des composés de formule (1) et des procédés pour la préparation de, des compositions contenant, et les utilisations de, ces dérivés. Les composés conformes à la présente invention sont utiles dans de nombreuses maladies et affections et dans de nombreux troubles, en particulier des maladies, affections et troubles inflammatoires, allergiques et respiratoires.DEPOSIT Company known as: PFIZER INC. PRIORITY CLAIMS EP 22 January 2004 04290169.4 GB 22 March 2004 0406387.1 US 9 Aug. 2004 60 / 600,260 See attached the title of the invention and the text of the abbreviated sulfonamide derivatives for the treatment of diseases The invention relates to compounds of formula (1) and processes for the preparation of, compositions containing, and uses of, these derivatives. The compounds according to the present invention are useful in many diseases and conditions and in many disorders, in particular inflammatory, allergic and respiratory diseases, conditions and disorders.

MA29201A 2004-01-22 2006-07-21 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MA28302A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09

Publications (1)

Publication Number Publication Date
MA28302A1 true MA28302A1 (en) 2006-11-01

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29201A MA28302A1 (en) 2004-01-22 2006-07-21 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES

Country Status (6)

Country Link
CR (1) CR9838A (en)
CY (1) CY1107107T1 (en)
EC (1) ECSP066700A (en)
HR (1) HRP20070542T3 (en)
IL (1) IL176564A (en)
MA (1) MA28302A1 (en)

Also Published As

Publication number Publication date
IL176564A0 (en) 2006-10-31
HRP20070542T3 (en) 2008-02-29
ECSP066700A (en) 2006-10-31
IL176564A (en) 2011-11-30
HK1096379A1 (en) 2007-06-01
CR9838A (en) 2008-04-21
CY1107107T1 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
MA27174A1 (en) NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS.
MA27452A1 (en) INDOLE DERIVATIVES USING BETA-2 AGONISTS
MA27840A1 (en) (2-HYDROXY-2- (4-HYDROXY-3-HYDROXYMETHYLPHENYL) -ETHYLAMINO) -PROPYLPHENYL DERIVATIVES AS BETA2 AGONISTS
MA30289B1 (en) Derivatives of amines
MA29170B1 (en) PURINIC DERIVATIVES AS A2A RECEPTOR AGONISTS
TN2009000112A1 (en) SULFONAMIDE DERIVATIVES AS ADRENERGIC AGONISTS AND MUSCARINIC ANTAGONISTS
MA32466B1 (en) TRIAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES
MA30911B1 (en) NOVEL SULFONAMIDE DERIVATIVES AS BRADYKININE ANTAGONISTS
MA31949B1 (en) Aminotriazole derivatives act as an antagonist of alx
MA27647A1 (en) CCR5 ANTAGONISTS USEFUL AS THERAPEUTIC AGENTS
MA30696B1 (en) (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL) -ACETIC DERIVATIVES
MA29411B1 (en) 1H-QUINAZOLINE -2,4-DIONES AND THEIR USE AS AMPA RECEPTOR LIGANDS
MA28747B1 (en) Pyridine Derivatives
MA27439A1 (en) NOVEL SPIROCONDENSIVE QUINAZOLINONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
MA27009A1 (en) PYRAZOLE DERIVATIVES FOR THE TREATMENT OF HIV INFECTION
MA27190A1 (en) TROPANE DERIVATIVES AS CCR5 MODULATORS
MA27451A1 (en) THIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
TN2010000230A1 (en) NEW AGONISTS OF GLUCOCORTICOID RECEPTORS
MA29213B1 (en) QUINOLONES WITH MACROLONES SUBSTITUTION - AMINO
MA27443A1 (en) NOVEL OXAZOLES AND THIAZOLES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS
MA29926B1 (en) PYRAZINE DERIVATIVES
SE0302760D0 (en) New compounds
MA30406B1 (en) NEW COMPOUNDS
TNSN08137A1 (en) CARBOXAMIDE DERIVATIVES AS ANTAGONISTS OF MUSCARINIC RECEPTORS
MA29377B1 (en) PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS